Scopus BioPharma Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Scopus BioPharma Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2023.
  • Scopus BioPharma Inc. Return On Equity for the quarter ending June 30, 2023 was 122 %.
  • Scopus BioPharma Inc. annual Return On Equity for 2022 was 285 %.
  • Scopus BioPharma Inc. annual Return On Equity for 2021 was -1.35K %, a 301% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 122 +4.14K Apr 1, 2023 Jun 30, 2023
Q1 2023 166 +3.59K Jan 1, 2023 Mar 31, 2023
Q4 2022 285 +1.64K Oct 1, 2022 Dec 31, 2022
Q3 2022 1.15K +5.19K Jul 1, 2022 Sep 30, 2022
Q2 2022 -4.02K -7.85K -205% Apr 1, 2022 Jun 30, 2022
Q1 2022 -3.42K -6.56K -209% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.35K -2.02K -301% Oct 1, 2021 Dec 31, 2021
Q3 2021 -4.04K Jul 1, 2021 Sep 30, 2021
Q2 2021 3.83K Apr 1, 2021 Jun 30, 2021
Q1 2021 3.14K Jan 1, 2021 Mar 31, 2021
Q4 2020 671 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.